Shih-Hon Li

Title: Innovations of Shih-Hon Li

Introduction

Shih-Hon Li is a notable inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of medical science, particularly in the development of compounds that target plasminogen activator inhibitor-1 (PAI-1). With a total of five patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

One of Shih-Hon Li's latest patents focuses on plasminogen activator inhibitor-1 (PAI-1) inhibitors and their methods of use. This patent outlines the development of compounds that can be utilized in treating diseases or disorders associated with elevated PAI-1 levels. The disclosure emphasizes the potential of these compounds to prevent or reduce thrombosis and fibrosis, promote thrombolysis, and modulate lipid metabolism. Additionally, it addresses the treatment of conditions related to elevated cholesterol or lipid levels.

Career Highlights

Throughout his career, Shih-Hon Li has worked with prestigious institutions such as the University of Michigan and Eastern Michigan University. His research and innovations have contributed to advancements in medical treatments and therapies.

Collaborations

Shih-Hon Li has collaborated with notable colleagues, including Daniel Lawrence and Cory Emal. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in his field.

Conclusion

Shih-Hon Li's contributions to the field of medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of diseases associated with elevated PAI-1 levels.